The first known allergic reaction to the Pfizer Covid-19 vaccine in the US was reported in Alaska as some snarls began to emerge in the effort to send the shots across the country, highlighting the daunting challenges ahead for a historic immunisation drive. A health care worker in Juneau, Alaska, with no history of allergies experienced flushing and shortness of breath 10 minutes after receiving a shot, the state health department said in a statement Wednesday.
The person was admitted to the emergency room and was given Pepcid, Benadryl and epinephrine through an intravenous drip. The patient stayed overnight and is in stable condition, according to the Alaska health department.
Pfizer is coordinating with local officials, will closely monitor all reports suggesting serious allergic reactions and will update labeling language if needed, spokeswoman Jerica Pitts said in a statement.
The incident came to light as the first hiccups in the distribution of the vaccine in the US emerged on Wednesday, including a holdup in delivering 3,900 shots to two states and the announcement that Pfizer would deliver about 900,000 fewer doses next week than are set to ship this week.
Pence to get vaccine shot on Friday; Biden next week
Vice-President Mike Pence will publicly receive the coronavirus vaccine on Friday, and President-elect Joe Biden is expected get vaccinated as soon as next week, amid concern that many Americans may refuse the injection. Meanwhile, California has reported more than 53,000 new coronavirus cases and 293 deaths.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
First Published: Fri, December 18 2020. 02:14 IST
read the full story about US Covid vaccine rollout hits snag as person falls sick after taking shot
#theheadlines #breakingnews #headlinenews #newstoday #latestnews #aajtak #ndtv #timesofindia #indiannews